All Stories

  1. Antimony(III) and Bismuth(III) Halide Complexes Containing Thiazole-and Thiadiazole-Based Mercapto Ligands: Synthesis, Structural Characterization, and Biological Activity
  2. Tetracycline as a Peroxidase Inhibitor: Possible Implications for Thyroid Hormone Biosynthesis
  3. Chirality-controlled biomolecular recognition in Cu( i ) metallodrugs: the first enantiomorphic CuP 2 O 2 ...
  4. Metalloantibiotic functionalized pHEMA for therapeutic contact lenses
  5. Antiosteolytic Bisphosphonate Metallodrug Coordination Networks: Dissolution Profiles and In Vitro/In Vivo Toxicity toward Controlled Release
  6. Monitoring Apoptotic Activity of Silver(I) Metallodrugs Containing Mefenamic Acid and Mitochondriotropic Agents in Artificial Breast Tumor Tissues
  7. Cobalt(II) Complexes of 4′-Bromo-Fenamic Acid: Antioxidant Properties, Antibacterial Activity, and Interaction with DNA and Albumins
  8. Silver(I) Ions Bridging Oxadiazole-2-thione Derivatives with Mitochondriotropic Agents: A Promising Strategy for Potent Anticancer Chemotherapy
  9. Investigating the antimicrobial activity of 1-heteroaryl benzotriazole silver compounds
  10. Group VA Aromatic Thiosemicarbazone Complexes: Synthesis, Characterization, Biological Activity, and Topological Studies
  11. Silver and Gold Compounds as Antibiotics
  12. Controlled dual activity of an organometallic antibiotic through micelle formulation
  13. Tetracycline: structural characterization and antimicrobial properties of its water-soluble di-anionic bi-sodium salt
  14. Non-Steroidal Anti-Inflammatory Drugs Loaded to Micelles for the Modulation of Their Water Solubility
  15. New Apoptosis Inducers Containing Anti-inflammatory Drugs and Pnictogen Derivatives: A New Strategy in the Development of Mitochondrial Targeting Chemotherapeutics
  16. Antiproliferative Activity of Antibiotics through DNA Binding Mechanism: Evaluation and Molecular Docking Studies
  17. Heteroleptic six-coordinate bismuth(iii) complexes with 2-acetylthiophene thiosemicarbazones: synthesis, characterization, and biological properties
  18. Antimicrobial Materials with Medical Applications
  19. Molecular Dynamics Simulation of 2-Benzimidazolyl-Urea with DPPC Lipid Membrane and Comparison with a Copper(II) Complex Derivative
  20. Silver Nanoparticles Using Eucalyptus or Willow Extracts (AgNPs) as Contact Lens Hydrogel Components to Reduce the Risk of Microbial Infection
  21. Silver Nanoparticles from Oregano Leaves’ Extracts as Antimicrobial Components for Non-Infected Hydrogel Contact Lenses
  22. Hydrogels containing water soluble conjugates of silver(i) ions with amino acids, metabolites or natural products for non infectious contact lenses
  23. Tetracycline Water Soluble Formulations with Enhanced Antimicrobial Activity
  24. Conjugation of Penicillin-G with Silver(I) Ions Expands Its Antimicrobial Activity against Gram Negative Bacteria
  25. Fluorescence of copper(I) and mixed valence copper(I/II) complexes with dipicolinic acid and their catalytic activity on catechol oxidation
  26. Ciprofloxacin conjugated to diphenyltin(iv): a novel formulation with enhanced antimicrobial activity
  27. Antiproliferative activity and apoptosis induction, of organo-antimony(III)–copper(I) conjugates, against human breast cancer cells
  28. An Efficient Disinfectant, Composite Material {SLS@[Zn3(CitH)2]} as Ingredient for Development of Sterilized and Non Infectious Contact Lens
  29. Structural architectures and biological properties of main group bismuth(III) iodide complexes with heterocyclic thioamides
  30. Synthesis, characterization and biological evaluation of novel antimony(III) iodide complexes with tetramethylthiourea and N-ethylthiourea
  31. Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives
  32. Diclofenac conjugates with biocides through silver(I) ions (CoMeD's); Development of a reliable model for the prediction of anti-proliferation of NSAID's-silver formulations.
  33. Non steroidal anti-inflammatory drug (NSAIDs) in breast cancer chemotherapy; antimony(V) salicylate a DNA binder
  34. The periodic table of urea derivative: small molecules of zinc(II) and nickel(II) of diverse antimicrobial and antiproliferative applications
  35. A water-soluble silver(I) formulation as an effective disinfectant of contact lenses cases
  36. Preface to “A Commemorative Issue in Honour of Professor Nick Hadjiliadis: Metal Complex Interactions with Nucleic Acids and/or DNA”
  37. Bismuth(III) bromide-thioamide complexes: synthesis, characterization and cytotoxic properties
  38. Poly Organotin Acetates against DNA with Possible Implementation on Human Breast Cancer
  39. Silver ciprofloxacin (CIPAG): a successful combination of chemically modified antibiotic in inorganic–organic hybrid
  40. Silver complex of salicylic acid and its hydrogel-cream in wound healing chemotherapy
  41. Innovative material containing the natural product curcumin, with enhanced antimicrobial properties for active packaging
  42. Cytotoxic effect, antitumour activity and toxicity of organotin derivatives with ortho- or para-hydroxy-benzoic acids
  43. Chloro(triphenylphosphine)gold(I) a forefront reagent in gold chemistry as apoptotic agent for cancer cells
  44. Synthesis, characterization and cytotoxic properties of bismuth(III) chloride complexes with heterocyclic thioamides
  45. New metalo-therapeutics of NSAIDs against human breast cancer cells
  46. Synthesis, characterization and biological activities of copper(II) complex of 2-Benzimidazolyl-urea and the nitrate salt of 2-Benzimidazolyl-urea
  47. Molecular Docking and Structure Activity Relationship Studies of NSAIDs. What do they Reveal about IC50?
  48. Synthesis characterization and biological activity of mixed ligand silver(I) complex of 2-benzimidazolylurea and triphenylphosphine
  49. QSAR studies on antimony(III) halide complexes with N-substituted thiourea derivatives
  50. Silver(I) complexes of methyl xanthate against human adenocarcinoma breast cancer cells
  51. N-(4-Hydroxyphenyl)acetamide against diiodine towards polyiodide dianion
  52. Platinum(II)-thiosemicarbazone drugs override the cell resistance due to glutathione; assessment of their activity against human adenocarcinoma cells
  53. Structural, photolysis and biological studies of novel mixed metal Cu(I)-Sb(III) mixed ligand complexes
  54. Nimesulide Silver Metallodrugs, Containing the Mitochondriotropic, Triaryl Derivatives of Pnictogen; Anticancer Activity against Human Breast Cancer Cells
  55. New antibacterial, non-genotoxic materials, derived from the functionalization of the anti-thyroid drug methimazole with silver ions
  56. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Metal Complexes and Their Effect at the Cellular Level
  57. Addition of tetraethylthiuram disulfide to antimony(III) iodide; synthesis, characterization and biological activity
  58. Novel bismuth compounds: synthesis, characterization and biological activity against human adenocarcinoma cells
  59. New antimony(III) halide complexes with dithiocarbamate ligands derived from thiuram degradation: The effect of the molecule's close contacts on in vitro cytotoxic activity
  60. Recent advances on antimony(III/V) compounds with potential activity against tumor cells
  61. Novel mixed metal Ag(I)-Sb(III)-metallotherapeutics of the NSAIDs, aspirin and salicylic acid: Enhancement of their solubility and bioactivity by using the surfactant CTAB
  62. Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs
  63. Mono-nuclear cis-Pd(II) chloride complex of the thio-nucleotide analogue 5-methyl-thiouracil and its biological activity
  64. Silver(I) compounds of the anti-inflammatory agents salicylic acid and p-hydroxyl-benzoic acid which modulate cell function
  65. Stability and binding effects of silver(I) complexes at lipoxygenase-1
  66. Assessment of organotins against the linoleic acid, glutathione and CT-DNA
  67. Antimony(III) halide compounds of thioureas: Structures and biological activity
  68. Mono- and Binuclear Copper(I) Complexes of Thionucleotide Analogues and Their Catalytic Activity on the Synthesis of Dihydrofurans
  69. A novel silver iodide metalo-drug: Experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione
  70. Synthesis, structural characterization and cytostatic properties of N,N-dicyclohexyldithiooxamide complexes of antimony(III) halides (SbX3, X: Br or I)
  71. Synthesis, characterization, and binding properties towards CT-DNA and lipoxygenase of mixed-ligand silver(I) complexes with 2-mercaptothiazole and its derivatives and triphenylphosphine
  72. Fundamental chemistry of iodine. The reaction of di-iodine towards thiourea and its methyl-derivative: formation of aminothiazoles and aminothiadiazoles through dicationic disulfides
  73. Novel metallo-therapeutics of the NSAID naproxen. Interaction with intracellular components that leads the cells to apoptosis
  74. Synthesis, antiradical activity and in vitro cytotoxicity of novel organotin complexes based on 2,6-di-tert-butyl-4-mercaptophenol
  75. Synthesis, characterization and biological activity of antimony(III) or bismuth(III) chloride complexes with dithiocarbamate ligands derived from thiuram degradation
  76. Synthesis, structural characterization and cytotoxicity of the antimony(III) chloride complex with N,N-dicyclohexyldithiooxamide
  77. Anti-proliferative and anti-tumor activity of silver(i) compounds
  78. The impact of the anion size on the crystal packing in 2-mercaptopyrimidine halides; isostructurality and polymorphism
  79. Comparative Binding Effects of Aspirin and Anti-Inflammatory Cu Complex in the Active Site of LOX-1
  80. Synthesis and Structural Characterization of New Cu(I) Complexes with the Antithyroid Drug 6- n -Propyl-thiouracil. Study of the Cu(I)-Catalyzed Intermolecular Cycloaddition of Iodonium Ylides toward Benzo...
  81. Photo-activated metallotherapeutics: copper(I) or silver(I) mixed ligand complexes with 2-mercaptopyrimidine and triphenylphosphine
  82. Synthesis, characterization and biological studies of new antimony(III) halide complexes with ω-thiocaprolactam
  83. Copper(I)/(II) or silver(I) ions towards 2-mercaptopyrimidine: An exploration of a chemical variability with possible biological implication
  84. Structural characterization of polymeric potassium salts with 2-thiobarbituric acid: influence of organotin(IV) chlorides on potassium cation solvation
  85. Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(iv) dichloride and its complexes
  86. Stabilization of poly-iodides: structural influences of the cationic disulfides of 2-mercapto-3,4,5,6-tetrahydro-pyrimidine and 2-mercatpo-pyrimidine
  87. Structural and In Vitro Biological Studies of Organotin(IV) Precursors; Selective Inhibitory Activity Against Human Breast Cancer Cells, Positive to Estrogen Receptors
  88. Reactivity of di‐iodine toward thiol: Desulfuration reaction of 5‐nitro‐2‐mercapto‐benzimidazole upon reaction with di‐iodine
  89. Mixed ligand–silver(i) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis
  90. Study on single crystal structure of the antimony(III) bromide complex with 3-methyl-2-mercaptobenzothiazole and biological activity of some antimony(III) bromide complexes with thioamides
  91. Interaction of antimony(III) chloride with thiourea, 2-mercapto-5-methyl-benzimidazole, 3-methyl-2-mercaptobenzothiazole, 2-mercaptopyrimidine, and 2-mercaptopyridine
  92. Bromidotris(triphenylphosphane)silver acetonitrile monosolvate monohydrate
  93. Synthesis, structural characterization and biological studies of novel mixed ligand Ag(I) complexes with triphenylphosphine and aspirin or salicylic acid
  94. Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid
  95. Uncertainty Analysis of Drug Concentration in Pharmaceutical Mixtures
  96. Anticancer and cytotoxic effects of a triorganotin compound with 2-mercapto-nicotinic acid in malignant cell lines and tumor bearing Wistar rats
  97. Structural characterization of the {3[ΗBPMTU]+ · 3[X]− · nH2O} salts (BPMTU = 1,3-bis(3-pyridylmethyl)-2-thiourea and X = Cl, Br, I). A polychlorine network based on O ··· Cl−and OH ··· Cl−i...
  98. Inhibition of peroxidase-catalyzed iodination by thioamides: experimental and theoretical study of the antithyroid activity of thioamides
  99. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides
  100. Structural, photolysis and biological studies of the bis(μ2-chloro)-tris(triphenylphosphine)-di-copper(I) and chloro-tris(triphenylphosphine)-copper(I) complexes. Study of copper(I)–copper(I) interactions
  101. Structural Properties, Cytotoxicity, and Anti‐Inflammatory Activity of Silver(I) Complexes with tris(p‐tolyl)Phosphine and 5‐Chloro‐2‐Mercaptobenzothiazole
  102. Structural Motifs and Biological Studies of New Antimony(III) Iodide Complexes with Thiones
  103. Current-driven vortex oscillations in metallic nanocontacts: zero-field oscillations and training effects
  104. Direct Current Control of Three Magnon Scattering Processes in Spin-Valve Nanocontacts
  105. Time-resolved zero field vortex oscillations in point contacts
  106. Palladium coordination compounds as anti-viral, anti-fungal, anti-microbial and anti-tumor agents
  107. New Antimony(III) Bromide Complexes with Thioamides: Synthesis, Characterization, and Cytostatic Properties
  108. Tetrameric 1:1 and monomeric 1:3 complexes of silver(I) halides with tri(p-tolyl)-phosphine: A structural and biological study
  109. Synthesis, structural characterization and in vitro cytotoxicity of new Au(III) and Au(I) complexes with thioamides
  110. Synthesis, Characterization, and Biological Studies of Organotin(IV) Derivatives with o‐ or p‐hydroxybenzoic Acids
  111. Antiproliferative and anti-tumor activity of organotin compounds
  112. Anticancer Therapeutics
  113. Structural and biological studies of organotin(IV) derivatives with 2-mercapto-benzoic acid and 2-mercapto-4-methyl-pyrimidine
  114. ChemInform Abstract: Synthesis, Structural Characterization and Biological Study of New Organotin(IV), Silver(I) and Antimony(III) Complexes with Thioamides
  115. Current-Driven Vortex Oscillations in Metallic Nanocontacts
  116. Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides
  117. Biological studies of new organotin(IV) complexes of thioamide ligands
  118. ChemInform Abstract: Interaction of Thioamides, Selenoamides, and Amides with Diiodine
  119. Structural motifs of diiodine complexes with amides and thioamides
  120. Crystal Structure and Antitumor Activity of the Novel Zwitterionic Complex of tri‐n‐Butyltin(IV) with 2‐Thiobarbituric Acid
  121. The influence of weak links on magnetic ordering in layered structures
  122. Synthesis, Structural Characterization, and Biological Studies of New Antimony(III) Complexes with Thiones. The Influence of the Solvent on the Geometry of the Complexes
  123. A room-temperature electrical field–controlled magnetic memory cell
  124. Biological studies of organotin(IV) complexes with 2-mercaptopyrimidine
  125. Magnetic and transport properties of Ni81Fe19∕Al2O3 granular multilayers approaching the superparamagnetic limit
  126. A New Silver(I) Aggregate Having an Octagonal Ag4S4 Core Where μ3‐S Bonding Interactions Lead to a Nanotube Assembly that Exhibits Quasiaromaticity
  127. X-ray scattering from two-dimensionally patterned magnetic thin film nanoscale arrays
  128. Synthesis, Structural Characterization, and Biological Studies of Six- and Five-Coordinate Organotin(IV) Complexes with the Thioamides 2-Mercaptobenzothiazole, 5-Chloro-2-mercaptobenzothiazole, and 2-Mercaptobenzoxazole
  129. Synthesis and Structures of Se Analogues of the Antithyroid Drug 6‐n‐Propyl‐2‐thiouracil and Its Alkyl Derivatives: Formation of Dimeric Se–Se Compounds and Deselenation Reactions of Charge‐Transfer Adducts of Diiodine
  130. Structural characterization of selenium and selenium-diiodine analogues of the antithyroid drug 6-n-propyl-2-thiouracil and its alkyl derivatives
  131. Novel organotin(IV) compounds derived from bis(organostannyl)methanes: Synthesis and crystal structures of bis[diphenyl(pyridin-2-onato)stannyl]methane and bis[bromophenyl(pyrimidine-2-thionato)stannyl]methane · C7H8
  132. Synthesis and characterization of a new chloro-di-phenyltin(IV) complex with 2-mercapto-nicotinic acid: Study of its influence upon the catalytic oxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme lipoxygenase
  133. Interaction of Thioamides, Selenoamides, and Amides with Diiodine
  134. Pressure‐Tuning Raman Spectra of Diiodine Thioamide Compounds: Models for Antithyroid Drug Activity
  135. Synthesis, structural characterization and study of {[K(H2mna)2]+· [K(μ-OH)2]−· 4H2O} (H2mna = 2-mercapto-nicotinic acid). A supramolecular architecture of inorganic/metal-organic hybrid self-assembled by strong hydrogen bonds and π–π interactions
  136. Synthesis, Structural Characterization, and Computational Studies of Novel Diiodine Adducts with the Heterocyclic Thioamides N-Methylbenzothiazole-2-thione and Benzimidazole-2-thione:  Implications with the Mechanism of Action of Antithyroid Drugs
  137. Sub-picosecond electron and phonon dynamics in nickel
  138. Synthesis and characterization of new water stable antimony(III) complex with pyrimidine-2-thione and in vitro biological study
  139. An Exploration of the Structural and Bonding Variability in Mixed‐Ligand Benzimidazole‐2‐thione(bromo)(triarylphosphane)dicopper(I) Complexes with Diamond‐Shaped Cu2(μ‐X)2 Core Structures
  140. Temperature-dependent magnetization and susceptibility ofFen∕
  141. 46 Pd The Use of Palladium Complexes in Medicine
  142. Microscopic model for femtosecond magnetization dynamics
  143. On the realization of artificial XY spin chains
  144. Synthesis, X-ray characterization and study of new ionic complexes of 2-pyridone, obtained by oxidation with I2
  145. Effects of non-steroid anti-inflammatory drugs in membrane bilayers
  146. Synthesis, X‐ray Characterisation and Studies of the New Ionic Complex [Bis(pyridin‐2‐yl) disulfide] Triiodide, Obtained by Oxidation of 2‐Mercaptopyridine with I2 − Implications in the Mechanism of Action of Antithyroid Drugs
  147. Excitonic enhancement of spin relaxation in diluted magnetic semiconductor quantum wells
  148. Crystallographic report: Diphenylbis(Hpiroxicam)tin(IV), [Ph2Sn(Hpir)2]
  149. Retrieving pulse profiles from pump-probe measurements on magnetization dynamics
  150. Synthesis, Characterization and in Vitro Study of the Cytostatic and Antiviral Activity of New Polymeric Silver(I) Complexes with Ribbon Structures Derived from the Conjugated Heterocyclic Thioamide 2-Mercapto-3,4,5,6-tetra- hydropyrimidine
  151. Organotin(IV) Derivatives of L‐Cysteine and their in vitro Anti‐Tumor Properties
  152. Synthesis, structural characterization and in vitro cytotoxicity of organotin(IV) derivatives of heterocyclic thioamides, 2-mercaptobenzothiazole, 5-chloro-2-mercaptobenzothiazole, 3-methyl-2-mercaptobenzothiazole and 2-mercaptonicotinic acid
  153. Synthesis and Characterization of (PTU)I2 (PTU = 6‐n‐propyl‐2‐thiouracil) and (CMBZT)I2 (CMBZT = 5‐chloro‐2‐mercaptobenzothiazole) and Possible Implications for the Mechanism of Action of Anti‐Thyroid Drugs
  154. Experimental access to femtosecond spin dynamics
  155. Synthesis, study and structural characterization of a new water soluble hexanuclear silver(I) cluster with the 2-mercapto-nicotinic acid with possible antiviral activity
  156. Communication: Synthesis of a Novel Triphenyltin(IV) Derivative of 2‐Mercaptonicotinic Acid with Potent Cytotoxicity in vitro
  157. High-pressure Fourier transform micro-Raman spectroscopic investigation of diiodine-heterocyclic thioamide adducts
  158. Copper(I) Halide Complexes with Triphenylphosphane and Heterocyclic Thione Ligands: The Crystal Structures of [Bis(Triphenylphosphane)(Benzimidazole-2-Thione)Copper(I) Iodide], [Bis(Triphenylphosphane)(Benzothiazole-2-Thione)Copper(I) Iodide], and Bis[...
  159. Synthesis, Spectroscopic and Structural Characterization of Novel Diiodine Adducts with the Heterocyclic Thioamides, Thiazolidine-2-thione (tzdtH), Benzothiazole-2-thione (bztzdtH) and Benzimidazole-2-thione (bzimtH)
  160. All-Optical Probe of Coherent Spin Waves
  161. Solvent-controlled assembling by hydrogen bridges and halogen-halogen interactions of novel organotin oxo clustersElectronic supplementary information (ESI) available: Synthesis and analytical data for PhI2SnCH2SnI2Ph. See http://www.rsc.org/suppdata/c...
  162. Laser-induced precession in canted-spin ferromagnets
  163. Femtosecond Magneto-Optics: Spin Dynamics in Ferromagnetic Layered Systems
  164. Synthesis, characterisation and study of mercury(II) bromide complexes with triphenylphosphine and heterocyclic thiones. The crystal structures of [bis(triphenylphosphine) dibromo mercury(II)] and [dibromo (pyrimidine-2-thionato) (triphenylphosphine) m...
  165. Silver(I) complexes with heterocyclic thiones and tertiary phosphines as ligands. Part 4. Dinuclear complexes of silver(I) bromide: the crystal structure of bis[bromo-(pyrimidine-2-thione)(triphenylphosphine)silver(I)]
  166. Synthesis, characterisation and study of mercury(II) chloride complexes with triphenylphosphine and heterocyclic thiones. The crystal structures of [(benzothiazole-2-thionato)(benzothiazole-2-thione)(bis-triphenylphosphine) chloro mercury(II)] and [(μ2...
  167. Ultrafast Magneto-Optics in Nickel: Magnetism or Optics?
  168. Femtosecond spin dynamics of epitaxial Cu(111)/Ni/Cu wedges
  169. Organotin adducts with pyrimidinethione: crystal structure of dimethyldi(pyrimidine-2-thiolato)tin(IV) and diphenyldi(pyrimidine-2-thiolato)tin(IV)
  170. Quantum Well States in Spin-Dependent Tunnel Structures
  171. Electron and Hole Spin Dynamics in Magnetic Semiconductors
  172. Synthesis, spectroscopic and computational studies plus crystal structure of [(bis-benzo-1,3-thiazolidine-2-thione) (bis-triphenylphoshine)copper(I)][chloro(benzothiazolidine-2-thione)(bis-triphenylphoshine)copper(I)]
  173. Palladium(II) and platinum(II) complexes of pyridine-2-carbaldehyde thiosemicarbazone with potential biological activity. Synthesis, structure and spectral properties. Extended network via hydrogen bond linkages of [Pd(PyTsc)Cl]
  174. Synthesis and characterisation of the first organotin complex of piroxicam. An extended network system via non-hydrogen, hydrogen bonding linkages and C–H  · · ·  π contacts
  175. Anti-inflammatory properties of diclofenac transition metalloelement complexes
  176. Synthesis and characterization of copper(I) complexes with triphenylphosphine and heterocyclic thione ligands: the crystal structure of (thiazolidine-2-thione)(bis-triphenylphosphine) copper(I) chloride
  177. Metal ion–drug interactions. Preparation and properties of manganese (II), cobalt (II) and nickel (II) complexes of diclofenac with potentially interesting anti-inflammatory activity: Behavior in the oxidation of 3,5-di-tert-butyl-o-catechol
  178. Electrochemical reduction of dinuclear copper(I) mixed ligand complexes with tri-m-tolylphosphine and heterocyclic thiones
  179. Preparation and spectral studies of dinuclear mixed-ligand copper(I) complexes. The crystal structure of bis[μ-s(pyridine-2-thione)(tmtp) copper(I) bromide]
  180. ChemInform Abstract: Low Valent Coinage Metal Coordination Compounds With Tertiary Phosphines and Thiones
  181. MIXED LIGAND COORDINATION COMPOUNDS OF COPPER(I) WITH HETEROCYCLIC THIONES AND TERTIARY PHOSPHINES. THE CRYSTAL STRUCTURE OF BIS (QUINOLINE-2-THIONE) BISTRIPHENYLPHOSPHINO COPPER(I) ETHYLSULFATE HEMIHYDRATE
  182. On the molecular structure of gold(I) complexes with heterocyclic thiones. The structure of bis(1,3-thiazolidine-2-thione) gold(I) chloride hydrate
  183. Four-coordinate copper(I) iodide complexes with triphenylphosphine and heterocyclic thione ligands. The crystal structure of [Cu(PPh3)2(pymtH)I]
  184. Study of the geometric preferences of copper(I) halide coordination compounds with triarylphosphines. Crystal structures of [CuCl{P(o-tolyl)3}]2 and [CuBr{P(o-tolyl)3}]2
  185. Study of the geometric preferences of copper(I) halide coordination compounds with triarylphosphines. Crystal structure of [Cu2I2{P(m-tolyl)3}3]
  186. Study of mixed ligand copper(I) complexes with tri-m-tolyl-phosphine (tmtp) and heterocyclic thiones. Crystal structures of bis[μ-S(benzimidazoline-2-thione)(tmtp) copper(I) chloride] and bis[μ-Br(thiazolidine-2-thione)(tmtp) copper(I)]
  187. Copper(I) complexes with tri-o-tolylphosphine and heterocyclic thione ligands. Crystal structures of [(pyrimidine-2-thione)(tri-o-tolylphosphine)copper(I) chloride] and [(pyridine-2-thione)(tri-o-tolylphosphine)copper(I) iodide]
  188. Electrochemical reduction of copper(I) mixed- ligand complexes with phosphines and heterocyclic thiones in acetonitrile solutions with glassy carbon electrodes
  189. Synthesis and photolysis of a new series of Cu(I) complexes with tri-o-tolylphosphine and heterocyclic thiones as ligands. The crystal structure of (thiazolidine-2-thione)(tri-o-tolylphosphine)copper(I)bromide
  190. Synthesis and photolysis of a new series of Cu(I) complexes with tri-m-tolylphosphine and heterocyclic thiones. The crystal structure of bis[μ-iodo(pyridine-2-thione)(tri-m-tolylphosphine)copper(I)]
  191. Synthesis and photolysis of mixed copper(I) complexes with thiones and tri-p-tolylphosphine or triphenylphosphine; X-ray crystal structure of bis[copper(I)(1,3-thiazolidine-2-thione) (tri-p-tolylphosphine)chloride]
  192. Synthesis and photochemical study of Cu(I) complexes with tri-p-tolylphosphine and heterocyclic thiones. The crystal structure of [CuCl(pymtH)(p-CH3C6H4)3P]2
  193. Interaction of Thioamides, Selenoamides and Amides with Di-iodine: A Study of the Mechanism of Action of Anti-thyroid Drugs